We assessed binocular grating visual acuity with the Teller acuity cards (TAC) in 3 -36-month-olds at risk for visual disorders. After 3-8 years, each child was assessed with the TAC and with a battery of tests of spatial and non-spatial vision. The initial TAC score: (1) was uncorrelated with any of the later measures; (2) had low positive, but high negative predictive value for the later tests; (3) had low sensitivity, but high specificity for identifying children with and without visual disorders, respectively. We concluded that early TAC grating acuity predicts visual outcome, but perhaps only for children with initially normal grating acuity.
Introduction
Over the past decade the Teller acuity card (TAC) test (McDonald, Dobson, Sebris, Baitch, Varner & Teller, 1985) has been widely adopted for both laboratory research and the clinical assessment of grating (resolution) visual acuity and its development in infants and nonverbal children (for a review see Dobson, 1993) . Derived from the more rigorous but time-consuming and procedurally complex preferential looking (PL) method (see Teller, McDonald, Preston, Sebris & Dobson, 1986) , the child is presented with a series of high contrast cards, each of which contains a black and white square-wave grating and a uniform gray field of matched average luminance. The spatial frequencies of the gratings range in half-octave steps from 0.3 to 38 cpd when viewed from 55 cm. Based on the seminal research of Robert Fantz in the 1960s, the observer assumes that if the infant can resolve the stripes in a particular grating, he or she will reliably show a visual preference for it over the gray field. The highest spatial frequency that elicits a consistent visual preference is taken as the estimate of visual acuity.
The TAC test provides an accurate and rapid estimate of visual acuity in about 5 min, and high completion rates for both monocular and binocular tests have been reported (for reviews see Dobson, 1993) . Several studies have also shown that the acuity estimates obtained with the TAC test are comparable to norms previously established with the PL method (McDonald et al., 1985; Teller et al., 1986) , and that the procedure has demonstrated consistently high inter-and intra-observer reliabilities, at least over the short term (McDonald et al., 1985; Hertz & Rosenberg, 1988; Lewis, Reed, Maurer, Wyngaarden & Brent, 1993; Mash, Dobson & Carpenter, 1995; Harvey, Dobson, Tung, Quinn & Hardy, 1999) . Though originally designed for use with infants, the TAC test has also proven useful for assessing other nonverbal and multi-handicapped children who were considered previously to be untestable (Teller et al., 1986; Preston, McDonald, Sebris, Dobson & Teller, 1987; Hertz & Rosenberg, 1988; Mohn, van Hof-van Duin, Fetter, de Groot & Hage, 1988; Courage, Adams, Reyno & Kwa, 1994) .
For these reasons, the TAC test has become recognized internationally as a rapid, reliable, and effective assessment tool for use in pediatric clinical settings, and has become a standard component of the ophthalmological examination of infants and young children at risk for visual disorders (e.g. low birth weight, Down syndrome, cerebral palsy). Consequently, assessments based on this test contribute significantly to the decisions that are made concerning the timing and effectiveness of interventions, and to educational management of children with visual deficits. Moreover, with increasing recognition of the need for preschool vision screening programs (Ciner, Schmidt, Orel-Bixler, Dobson, Maguire, Cyert et al., 1998) , tests such as the TAC will likely receive widespread use with toddlers and preschoolers in the general population. Given the impact that early decisions regarding the status of children's visual development can have on their long-term well-being, it is a matter of concern that recent empirical research on the long-term reliability and predictive validity of the TAC test has yielded equivocal findings.
In an early examination of this issue, Courage and Adams (1990) conducted a longitudinal study of 27 full-term infants who were tested binocularly with the TAC test at least twice (mean test -retest interval = 5 months) within the first postnatal year. They found that in general, an early estimate of visual acuity was not predictive of a later estimate. More recently, Mash and Dobson (1998) examined the predictive characteristics of the TAC test in a prospective study of infants at risk for visual disorder due to preterm birth or perinatal complications. They found that monocular TAC scores at 4, 8, 11, 17, 24 and 36 months correlated with TAC scores (except at 17 months) and with HOTV recognition acuity scores at 48 months. However, the proportion of follow-up variance that was accounted for by the earlier TAC scores was low, especially for children under 2 years of age. In addition to these estimates of long-term reliability and predictive and concurrent validity, Mash and Dobson assessed the diagnostic accuracy or the predicti6e 6alue of the TAC test. Predictive values are categorical measures that provide an estimate of the probability that an initial positive (abnormal) test result, or an initial negative (normal) test result indicates that the child will also have abnormal or normal visual acuity, respectively, at follow-up. Mash and Dobson (1998) found that for both TAC and HOTV tests at 48 months, the predictive values of the earlier TAC assessments for the later outcome measures were higher (range 0.73 -0.84) for infants whose visual acuities were within the normal range on the earlier test (termed negati6e predictive value), than for those whose TAC acuity scores were initially below (range 0.39-0.69) the normal range (termed positi6e predictive value). Moreover, among these latter children, the developmental course of visual acuity was more variable. This pattern of results was replicated by Dobson, Quinn, Siatkowski, Baker, Hardy, Reynolds et al. (1999) in a large sample of preterm infants tested with the TAC test at 1 year and with the TAC test and the Snellen Letter Chart at 5.5 years. They found low but significant correlations between infant and childhood measures which accounted for only 2.9% (Snellen) and 13% (TAC) of the variance. However, predictive value analyses indicated that infants who had normal TAC acuities at 12 months also had normal TAC (94.3%) and Snellen (86.8%) acuity scores at 5.5 years. As few 12-month-olds in this sample had abnormal TAC scores, positive predictive values could not be calculated. Results of research in which the more rigorous PL methodology also yielded consistent findings. That is, in both normal and clinical populations: (1) longterm reliability coefficients were highest when the initial measure was taken in the first postnatal year; and (2) an early visual acuity measure provided high negative, and relatively poor positive predictive values (Maurer, Lewis & Brent, 1989; Birch & Bane, 1991; Birch & Spencer, 1991; Birch, Swanson, Stager, Woody & Everett, 1993; Saunders, Westall & Woodhouse, 1996) .
To date, there have been no follow-up reports in which measures other than grating or recognition visual acuity have been examined in relation to an early measure of TAC acuity. This is a significant omission in the literature, as children such as those in our sample are at risk not only for visual acuity loss, but also for deficits in other areas of visual functioning (see Fielder, Foreman, Moseley & Robinson, 1993) . Moreover, as visual acuity is a sensitive marker of visual function, and one that can provide an early index of many visual system disorders (see Schwartz, 1999) , the clinical utility of the TAC test would be enhanced if its predictive characteristics for other visual functions were known. The research we report here is a follow-up study of visual outcome in a group of infants and children who were first evaluated with the TAC test when they were between 2 and 42 months of age. These children were considered to be at risk for visual impairment because of preterm birth or significant perinatal or neonatal complications. Approximately 5 years later, when they were between 3 and 10 years old, we retested them with the TAC test and with a comprehensive battery of standard tests of visual function. Our primary goal was to examine the effectiveness of an early childhood measure of binocular grating acuity for predicting a broad spectrum of later measures of visual functioning, including resolution (TAC test) and standard recognition visual acuity, contrast sensitivity, stereoacuity, visual fields, color vision and ocular alignment/motility. In addition, our data extend the age range for studies of visual outcome in children born 'at risk' beyond that which has been reported to date.
Method

Participants
The participants were 76 children (38 males, 38 females) between the ages of 35 and 122 months (M = 78 months, SD= 24.4 months) who had experienced one or more of the following complications in the perinatal or neonatal periods which placed them at risk for developmental delay: birth weight B 1500 g (n =19), gestational ageB30 weeks (n =10), respiratory distress syndrome (n =30), bronchopulmonary dysplasia (n = 5), pneumothorax (n= 4), grade III or higher intraventricular hemorrhage (n =10), persistent neurological signs (n= 16) or seizures (n =6) during the first week of life, birth asphyxia (n=20), significant neonatal hypoglycemia (n = 6), patent ductus arteriosus (n = 9), necrotizing enterocolitis (n = 5), recurrent apnea (n = 17), head circumference B2 SD below the age-appropriate mean at discharge (n=14), retinopathy of prematurity (n = 1; grade III). The mean birth weight and gestation of the sample were 2416.3 g (SD=996) and 35.3 weeks (SD =4.7), respectively.
These children were part of a larger, similarly heterogeneous, at-risk sample (n = 349) who, as infants, had been referred to a developmental clinic for regular well-baby check ups, assessment with the Griffiths Developmental Scales from medical staff, and at least one binocular assessment with the Teller acuity cards (TAC) from our research team. The initial testing (Phase 1 of the present report) took place between 1990 and 1995 and the mean age of the participants at this first TAC assessment was 13.2 months (SD=11.7; range = 2-42 months). Selection of the participants for the follow-up phase of the study (Phase 2) depended entirely on the child's availability for testing (102 still resided within the region) and the caregiver's willingness to have the child participate (n = 76). To ensure that our sample was representative of the whole group of 349 children, a group of 76 cases was chosen at random from the original sample and compared to our follow-up sample on the following variables: birth weight, length of gestation, days of ventilation, grade of intraventricular hemorrhage, Griffiths Developmental Quotient in infancy, TAC test score during infancy, and the number of perinatal risks experienced. The results of t-tests comparing the two groups showed no significant differences on any of these variables (all P \ 0.28). The testing protocols for both the Phase 1 and Phase 2 sessions were approved by hospital and university ethical review committees, and informed consent was obtained from the children's caregivers prior to testing. Feedback concerning any abnormal test performance was reported either to medical staff at the developmental clinic (Phase 1), or to the children's caregivers (Phase 2).
Procedure
In Phase 1, the children's binocular grating visual acuity was assessed with the Teller Acuity Cards (Vistech Consultants Inc., Dayton, OH) in accordance with the standard testing procedure recommended in the TAC Handbook (1989) . The TAC test consists of 16 cards with a 12.5× 12.5 cm grating to the left or right of each card's central peephole, and one blank gray card. A naive observer presents each card and, after a series of trials, judges whether the child can resolve the grating on that card by recording his or her visual (and any other) preference behavior towards it. The highest spatial frequency (e.g. 0.3 through 38 cycles/deg at a distance of 55 cm) that a child can resolve is taken as the estimate of grating visual acuity.
In Phase 2, the children were evaluated with 12 standardized tests, which collectively, assessed six major areas of their visual functioning: visual acuity, contrast sensitivity, stereoacuity, peripheral vision, color vision, and ocular alignment/motility. Testing took place in a laboratory setting illuminated at 9 300 lux (GE F40-C75 fluorescent tubes) and at a correlated color temperature of 6500 K (measured in situ) which is recommended for color vision testing. If a child had been prescribed corrective lenses, they were worn during testing. To be consistent with Phase 1 of the procedure, all of the Phase 2 tests were conducted binocularly and in accordance with the recommended standardized procedures for each test. The test battery included the following measures: (1) Visual acuity: (a) resolution acuity was assessed with the Teller Acuity Cards as described above (b) recognition acuity, both near (40 cm) and distance (3 m) estimates, were determined for each child using the Snellen letter (GrahamField Co.), HOTV (Bernell Corp., South Bend, IN), Tumbling (or Illiterate) E charts (Good-Lite Co., Forest Park, IL), and the Broken Wheel Test (picture recognition Landolt C optotype) (Bernell Corp). Pass criterion for each test is B 2 errors per target size. (2) Contrast sensitivity: The Vistech CS test chart (Vistech Consultants, Inc., Dayton, OH) consists of sine-wave gratings systematically arranged by spatial frequency (1.5, 3, 6, 12 or 18 cpd) and contrast (from 9 30 to 9 0.3% or CS= 3.3-333.3). Test distance was 3 m. (3) Stereoacuity: The Stereo Fly Test (Stereo Optical Co., Chicago, IL) stimuli are viewed at a distance of 40 cm and have specific crossed disparities ranging from 3000 to 40 s of arc). (4) Peripheral vision: The extent of the horizontal binocular visual field was assessed with the Field of Vision Disk (Hubbard Scientific, Chippewa Falls, WI). (5) Color vision: The preschool portion (plates 26-38) of the Ishihara Pseudoisochromatic Color Plates (Kanehara and Co., Tokyo, Japan) was used to screen for protan and deutan red-green color vision deficiencies. Test distance was 40 cm. (6) Ocular 
Results
Test completion
Of the 76 children who participated in the follow-up (Phase 2), 38 (50%) completed all 12 of the tests (M = 7.6 tests; SD=1.9; range=2 -12). The number of tests completed was correlated significantly with age (r = 0.57, P B0.001). The mean test session duration was 29.2 min (SD= 11.3 min).
Data analysis
The Teller acuity card (TAC) scores (cpd) for each infant and child at both initial (Phase 1) and followup (Phase 2) testing were log-transformed for statistical analysis. As the children's ages ranged widely from 2 to 42 months at the Phase 1 test and from 35 to 122 months at the Phase 2 tests, the TAC test scores were converted to their standard (z-score) equivalents, based on age-appropriate means and standard deviations reported for full term infants and children of equivalent postconceptional age (see . The Phase 2 recognition acuity measures (also in cpd, with the convention that 20/20 Snellen, HOTV, Illiterate E, and Broken Wheel approximates 30 cpd), were log transformed for analysis.
To calculate the positive and negative predictive values, the sensitivity and specificity of the TAC test, and to compare the Phase 1 TAC measure with the Phase 2 measures of visual function, the follow-up test scores were categorized as 'normal' or 'abnormal'. These category designations were based on standardized test norms and the criteria used in clinical practice for classifying visual performance on those functions.
1 In addition, to afford the TAC test the highest screening power, children's Phase 2 visual acuity was also given a composite, 'worst case' evaluation based on the most subnormal (i.e. worst) estimate obtained on any of the Phase 2 visual acuity tests. For this evaluation, categories were 'normal', 'suspect' or 'abnormal'. These Phase 2 'worst' rankings were compared with corresponding Phase 1 TAC scores which were also converted to 'normal', 'suspect' and 'abnormal'. To avoid bias, Phase 1 and Phase 2 classifications were made independently.
3.3. Phase 1: initial 6isual acuity assessment with the Teller acuity cards (TAC1)
To facilitate comparison among children, the data were collapsed into the following age (corrected) groups: 3-months-olds (n= 21; M=3.1 months; SD= 0.72 months); 6-months-olds (n= 17; M= 6.5 months; SD= 1.3 mo); 12-months-olds (n= 18; M= 12.6 months; SD= 2.6 months); 24-months-olds (n=8; M= 20.0 months; SD= 2.6 months); and 36-months-olds (n= 12; M= 36.5 months; SD= 2.8 months). The mean TAC1 score for each age group (cpd) and its standard score equivalent are shown in Table 1 .
As can be seen from these data (notably the z-scores), the TAC scores of the high-risk children who were first 1 Standard developmental norms used to designate normal, suspect, or abnormal vision: (1) Teller acuity cards: from the data in Courage and Adams (1990) ; children who scored higher than −1 SD below the mean were normal, between − 1 and −2 SD were suspect, and lower than − 2 SD were abnormal. (2) Near and distant recognition acuity (Snellen, Tumbling Es, HOTV) and the field of vision scores were categorized based on the Canadian Ophthalmological standards reported in the literature. (3) Broken wheel acuity norms and cut-off scores for normal and abnormal performance were provided by the Preschool Enrichment Team, Inc. (4) Contrast sensitivity norms from Courage, Piercy and Adams (1997) and from Vistech, Inc. were used to identify children as normal if data from all five spatial frequencies were higher than − 2 SD below the mean, and abnormal if at least one of the five values was lower than −2 SD. (5) Ishihara Color Plates norms were provided by Kanehara & Co., Inc., which include cut-off scores for identifying mild and strong protan and deutan types. (6) Stereo fly test norms were from Tatsumi and Tahira (1972) , and include cut-off scores for identifying normal, abnormal, and suspect cases. tested when they were either 3-or 6-months-old were within the normal range compared to age norms from the full term infants, whose mean z-scores = 0. t-tests confirmed that the mean differences between the highrisk infant scores in these two age groups and those of the full-term infants were not significant. However, the TAC test z-scores for those high-risk children who were about 12-, 24-, or 36-months-old when first tested were more than 1 SD below the respective means for fullterm, low-risk children, a difference that was significant at all ages: t(17)= −3.53, P B0.003; t(7) = −2.86, P B 0.02; t(11)= −2.91, P B0.01 for the 12-, 24-and 36-month groups, respectively.
Phase 2: follow-up assessment of 6isual functions
As the primary goal of this study was to evaluate the predictive characteristics of the TAC test for later visual functioning, a series of quantitative and qualitative analyses were conducted on the Phase 2 data vis-a-vis the Phase 1 TAC data. These analyses consisted of (1) correlation coefficients (either Pearson, Spearman, or point-biserial correlations, as appropriate) between the Phase 1 estimate of grating visual acuity (TAC1) and the Phase 2 measures of grating visual acuity (TAC2), recognition visual acuity, contrast sensitivity, color vision, peripheral vision, stereopsis, and ocular alignment/motility; (2) estimates of the positive and negative predictive values of the Phase 1 TAC estimate for later Phase 2 measures; (3) the sensitivity and specificity of the TAC for identifying children who had (or did not have) normal or abnormal vision; (4) the global validity of the TAC test, a weighted estimate of the effectiveness of the TAC for correctly identifying cases of normal and abnormal visual functioning. 
Quantitati6e analyses: correlation coefficients
As can be seen in Fig. 1 , for the whole group, TAC z-scores at Phases 1 and 2 were uncorrelated (r= − 0.04). Likewise, Phase 1 TAC scores were uncorrelated with Phase 2 scores for either near (r=0.05) or distance 2 Estimates of a test's sensitivity and specificity are the traditional statistics used to report its diagnostic accuracy in the psychometric and clinical literatures (see Wissow, 1997) . Specifically, the sensitivity and specificity of a test (e.g. the Teller acuity cards) refer to its success in identifying individuals who have or do not have, respectively, a particular disease or condition (e.g. subnormal visual acuity). On the other hand, a test's positive and negative predictive values provide estimates of the likelihood that a positive result means that a particular condition will be present (i.e. positive predictive value) and that a negative result means that the condition will be absent (i.e. negative predictive value). These two sets of test characteristics are related in that both provide information on how well a normal (negative predictive value; specificity) estimate or an abnormal (positive predictive value; sensitivity) estimate of performance predicts ultimate functioning. They differ in that sensitivity/specificity are test accuracy statistics, whereas predictive values provide estimates of the confidence that a user can have in the expected outcome.
(r =0.08) recognition acuity. When these correlations were calculated for each age group individually, none of the correlations between initial TAC1 scores and subsequent measures of grating (TAC2) or recognition acuity were significant (range= −0.43 to 0.36). Finally, Phase 1 TAC (categorized) scores and the 'worst case' ratings of each child's Phase 2 performance were uncorrelated, either for the whole group (r= 0.07) or for any of the age subgroups (range = −0.27 to 0.40).
To compare the Phase 1 TAC z-scores with Phase 2 performance on contrast sensitivity, color vision, peripheral vision, stereopsis, and ocular alignment/motility, the follow-up results were categorized as either normal or abnormal. The results of point-biserial correlations revealed that the TAC1 z-scores were not associated with any of the outcome measures of visual functioning at any age (range 0.03 -0.45, all P \0.05).
Qualitati6e analyses (1): predicti6e 6alue of an early grating acuity measurement (TAC1) for later tests of functional 6ision
To calculate positive and negative predictive values, each subject's Phase 1 TAC score and his or her Phase 2 test scores were classified as either normal or abnormal. Following Mash and Dobson (1998) , the predictive value for a negative (normal) test was found by dividing the number of subjects with normal test results at both the Phase 1 and Phase 2 sessions by the number of subjects with normal TAC results at Phase 1, regardless of his/her Phase 2 test result. Similarly, the predictive value for a positive (abnormal) test was calculated by dividing the number of subjects with abnormal test results at Phase 1 and at Phase 2 by the number of subjects with abnormal TAC results at Phase 1, regardless of Phase 2 performance. Predictive values were calculated for the at-risk group as a whole and, where numbers permitted, for each of the age subgroups. These analyses yielded three findings of note. First, as shown in Table 2 , the negative (normal) predictive values of the Phase 1 TAC test were very high for all of the Phase 2 tests, both for the group as a whole (M= 0.91) as well as for the individual age subgroups (range of means=0.85-0.96). Second, the positive (abnormal) predictive values for the group as a whole were low -contrast sensitivity 0.40; near acuity 0.00; distance acuity 0.36; TAC2 0.00; Broken Wheel 0.11; Ishihara plates 0.00; stereoacuity 0.17; peripheral vision 0.45; ocular alignment/motility 0.50. On average, only 23% of tests showing an abnormal TAC1 result at Phase 1 were predictive of an abnormal result at Phase 2. Third, concerning the TAC test itself (TAC1 versus TAC2), the negative predictive value was high for the whole group (0.98) and for all of the subgroups (range= 0.95-1.00), whereas the positive predictive value for the whole group (n= 14) was negligible (0.00).
Qualitati6e analyses II: sensiti6ity, specificity, and global 6alidity of an early measurement of grating acuity (TAC1)
To calculate specificity and sensitivity values, each subject's Phase 1 TAC test result and his or her Phase 2 test results were classified as either normal or abnormal. Following Vital-Durand, Ayzac and Pinzaru (1996) , specificity values were defined as the number of normal TAC tests that occurred at both Phases 1 and 2, divided by the number of normal tests that occurred at Phase 2 (regardless of the result obtained at Phase 1). Similarly, sensitivity was defined as the number of abnormal tests that occurred at Phases 1 and 2, divided by the number of abnormal Phase 2 tests (regardless of the Phase 1 result). Sensitivity and specificity scores were calculated for the at-risk group as a whole and, where numbers permitted, for the age subgroups. The results shown in Table 3 indicate that the TAC test was a highly specific test for the group as a whole (M = 0.84), and especially so for the 3-, and 6-month subgroups (means= 0.94 and 0.97, respectively). It was somewhat less specific for the 12-and the combined 24-and 36-month subgroups (means= 0.80 and 0.71, respectively). In contrast to the generally high specificity, sensitivity scores were very low for the group as a whole: contrast sensitivity 0.40; distance acuity 0.40; stereoacuity 0.25; peripheral vision 0.38; ocular alignment/motility 0.47. Because of the low frequency of abnormal tests, sensitivity scores were not calculated for the age subgroups. Finally, global 6alidity calculations for the TAC test (i.e. a weighted mean of sensitivity and specificity) (see Vital-Durand et al., 1996) ranged from 0.74 to 0.85 across tests, and from 0.70 to 0.91 across subgroups.
Discussion
Phase 1 of the study showed that in high-risk infants, a measure of grating acuity taken with the Teller Acuity Cards (TAC1) at 3-and 6-months, was comparable to that of a normative sample of age-matched, full term infants and children without perinatal complications or other risk factors. However, grating visual acuity of high-risk 12-, 24-, and 36-month-olds was significantly poorer than that of the normative sample. This finding is consistent with the results of other research with high-risk samples in which infants and children with Down syndrome (Courage et al., 1994) and extremely low ( B 1000 g) birth weight showed normal TAC test acuities when tested within the first 6 months of postnatal life, but poorer acuities when tested after that age. Although the reason for this developmental pattern is unknown, it is of note that the first 6 postnatal months is a time of rapid development and reorganization within the visual system (see Huttenlocher, 1994) , and one in which aberrant development in a particular domain may not become evident until the system stabilizes. Interestingly, in spite of the serious perinatal risks experienced by the infants in our sample, their visual acuities, though below the mean between 12-and 36-months of age, were generally within the clinically normal range (see also Mash & Dobson, 1998) .
The primary goal of the study reported here was to evaluate the predictive characteristics of a single, early measure of grating visual acuity (TAC1) in relation to a variety of follow-up measures of visual functioning taken during mid-childhood. To do this, we first conducted correlational analyses which afford what many have considered to provide the traditional 'gold standard' evaluation of a test, that is, quantitative estimates of its reliability and validity. Reports of these statistical properties for the TAC test with full term, normally developing infants have been moderate to high, (Mash et al., 1995; Mayer, Beiser, Warner, Pratt, Raye & Lang, 1995; Salomao & Ventura, 1995) , with significant but more modest correlations among high-risk groups, at least over the short term (e.g. Maurer et al., 1989; Mash & Dobson, 1998) .
In the research reported here, we found that an early TAC measure of grating (resolution) acuity was uncorrelated with a second TAC measure taken about 5 years later, or with any of our later measures of visual functioning. This unexpected finding may be due in part to the restricted variance of Phase 2 test scores which were at or near ceiling for most of the children at the follow-up, a condition that may have masked the predictive power of the early TAC test. These findings suggest on one hand that an early estimate of visual acuity taken with the TAC test has little long-term reliability or predictive validity. On the other, it is of note that our range of correlations for the age sub-groups were comparable to the statistically significant correlations for a much larger sample of infants (Mash & Dobson, 1998; Dobson et al., 1999) .
Although the long-term reliability of the TAC test appears to be modest at best, a more clinically useful measure of the diagnostic accuracy of the TAC test is its predictive value. In contrast to the non-significant findings from our correlational analyses, we found that across all age subgroups, a negative (normal) TAC assessment taken in infancy or early childhood had high negative (normal) predictive value for later measures of grating acuity (TAC2), recognition acuity, contrast sensitivity, stereoacuity, color vison, and ocular alignment/motility. Although the small numbers of children with abnormal test scores in either Phase 1 or Phase 2 of our research precluded estimation of positive predictive values for some measures, those that we could estimate (contrast sensitivity, distance recognition acuity, stereoacuity, ocular alignment/motility), were much lower than for the corresponding negative predictive values. Consistent with these findings, sensitivity and specificity analyses indicated that the TAC test was highly specific for identifying children with normal vision as assessed by our tests, but much less sensitive for identifying children with abnormal vision.
What these findings imply is that when an infant or young child has a TAC test score that falls within the normal range for his or her age, it is highly likely that the child in fact has normal vision, and that he or she will also be scored as having normal vision on subsequent outcome measures. However, it is important to note that the greater proportion of normal versus abnormal results at both testing ages (by nature, a finding also observed in the general population) increases substantially the probability of finding high negative predictive value and specificity. This implies that the importance of such values may be inflated artificially, and this should be interpreted with some caution. In contrast, if a child's TAC test score falls below normal in infancy or early childhood, no judgement of his or her future visual status can be made with confidence, although additional follow-up assessment and monitoring are clearly warranted. In spite of the equivocal status of the TAC test for identifying and predicting outcome for infants and children who have abnormal visual function, the information that research has provided to date is important and informative. Specifically, when the TAC test is used in comprehensive population-based screening programs, a large number of children with normal vision will be identified. This positive finding notwithstanding, it is important to remember that for researchers and practitioners alike, it is the smaller proportion of children who will have abnormal vision that most urgently needs to be identified. For these latter children who are most at risk (though some of them will subsequently have normal vision), timely interventions adapted to their particular deficits can improve outcome in many cases (e.g. see Sonksen, Petrie & Drew, 1991) . Consequently, any decision to limit diagnostic and follow-up resources to children with abnormal TAC test scores could be premature.
The findings that we reported here are consistent with other prospective studies of visual acuity. For example, Dobson and her colleagues (Mash & Dobson, 1998; Dobson et al., 1999) found substantial negative (normal) predictive values of the TAC test for outcome measures of grating visual acuity (TAC test) and recognition (HOTV) acuity, but much lower estimates of positive (abnormal) predictive values for subsequent outcome measures. In similar analyses based on traditional preferential-looking measures of grating visual acuity, Saunders et al. (1996) reported that 69% of full-term infants who had grating visual acuity above the mean in the first year of life maintained that level, whereas infants with below average grating acuity showed more variability in their development, with only 21% maintaining their position below the mean.
The reason underlying the poor positive predictive value and sensitivity of the TAC is unknown and will require further research in which larger numbers of children with below normal visual acuity are tested. Ideally, this research should be prospective and longitudinal, as there is evidence that the developmental course of infants and young children with abnormal visual functioning may be more variable than that of children with normal vision. For example, infants who have been identified as having 'delayed visual maturation' are those who have below-normal visual functioning, often in the absence of any identifiable ocular or ophthalmic disorder, neurological abnormality, or developmental delay. As visual functioning often improves in these infants without specific treatment (for a review see Hoyt & Good, 1993) , an early measure of abnormal visual function may be inconclusive with regard to later visual outcome. Converging support is also provided by van Hof-van Duin, Cioni, Bertucchelli, Fazzi, Romano and Boldrini (1998) who found that even in a group of infants at high risk for visual deficit due to confirmed neonatal encephalopathy or severe perinatal brain lesions (i.e. cerebral visual impairment), visual outcome at 5 years was not well predicted by an early assessment with the TAC.
In conclusion, the results reported here, taken with other research, indicate that although there can be very severe, long-term visual deficits among preterm children, many of them score below their corrected age norms in infancy but remain within a 'clinically normal' range. As for the future of these children, our results show that although measures of visual acuity taken with the TAC test in infancy or early childhood were not good quantitative predictors of visual performance about 5 years later, the TAC test had very high specifi-city and negative predictive value (though not 100%) for identifying children with normal visual outcomesa finding that must be interpreted cautiously. In contrast, the sensitivity and positive predictive values of the TAC for identifying abnormal outcomes were much lower. An important practical implication of these findings is that the results a single TAC test should not be the basis of a decision to limit diagnostic resources to children with abnormal TAC test scores, at least until further research on the developmental course(s) of children with abnormal vision has been conducted.
